- Home
- BDTX vs VIOT Comparison
BDTX vs VIOT Comparison
Compare BDTX & VIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDTX | VIOT |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 109.1M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BDTX | VIOT |
|---|---|---|
| Price | $1.89 | $1.30 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 761.0K | 417.4K |
| Earning Date | 11-05-2026 | 08-27-2026 |
| Dividend Yield | N/A | ★ 4.71% |
| EPS Growth | ★ 130.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.78 |
| P/E Ratio | ★ N/A | $3.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.60 | $0.66 |
| 52 Week High | $4.94 | $3.53 |
Technical Indicators
Market Signals| Indicator | BDTX | VIOT |
|---|---|---|
| Relative Strength Index (RSI) | 48.71 | 46.54 |
| Support Level | $1.79 | $1.20 |
| Resistance Level | $1.93 | $1.50 |
| Average True Range (ATR) | 0.13 | 0.12 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 50.93 | 12.77 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.
About VIOT Viomi Technology Co. Ltd
Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.